Merck Must Turn Over Docs In Fosamax MDL: Judge

Law360, New York (June 6, 2008, 12:00 AM EDT) -- The judge overseeing the multidistrict litigation over the osteoporosis drug Fosamax has ruled that Merck & Co. Inc. must divulge materials dating back to 1998, despite the company's stance against turning over certain pre-2003 materials.

Merck had objected to producing certain documents or information relating to Fosamax before September 2003, the date when it says a temporal association between osteonecrosis of the jaw and bisphonates was first reported in medical literature.

While U.S. District Judge John Keenan's Thursday ruling did enlarge the scope of discovery, he...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.